Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» IPOs
IPOs
Contineum Dials Back Plans with $110M IPO to Fund Neuroinflammatory Trials
BioSpace
Fri, 04/5/24 - 11:32 am
Contineum Therapeutics
IPOs
neuroinflammation
Fierce Biotech's Quarterly IPO and M&A Roundup: Q1'24
Fierce Biotech
Wed, 04/3/24 - 11:36 am
biotech
M&A
IPOs
CG Oncology
Kyverna Therapeutics
Contineum Therapeutics
Boundless Bio
CymaBay Therapeutics
Gilead Sciences
MorphoSys
Novartis
Fusion Pharmaceuticals
AstraZeneca
Ambryx
JNJ
Inhibrix
Aventis
Neuro and inflammation biotech Contineum Therapeutics sets terms for $150 million IPO
Renaissance Capital
Mon, 04/1/24 - 12:25 pm
IPOs
Contineum Therapeutics
IPF
multiple sclerosis
Boundless Bio breaks IPO lull with $100M fundraise
BioPharma Dive
Wed, 03/27/24 - 10:37 pm
Boundless Bio
IPOs
Bayer
Arch Venture Partners
cancer
Galderma sets IPO price at top of range, or 53 Swiss francs a share
Reuters
Thu, 03/21/24 - 11:40 am
Galderma
IPOs
Boundless Bio eyes $88M offering as spring biotech IPO market blooms
Fierce Biotech
Thu, 03/21/24 - 11:32 am
Boundless Bio
IPOs
Boundless Bio, a Bayer-backed cancer biotech, seeks an IPO
BioPharma Dive
Thu, 03/7/24 - 11:13 am
Boundless Bio
IPOs
Bayer
Arch Venture Partners
Biotech IPOs heated up to start 2024. Will the surge last?
BioPharma Dive
Tue, 03/5/24 - 11:06 am
IPOs
biotech
Everyone's Talking About These 2 Biotech IPO Stocks
Motley Fool
Sun, 02/25/24 - 08:55 pm
biotech
IPOs
Kyverna Therapeutics
CG Oncology
Biopharma R&D Funding Has Rebounded But Clinical Trial Starts Slowed Down in 2023, Says IQVIA Institute
Managed Healthcare Executive
Thu, 02/22/24 - 11:21 pm
clinical trials
R&D
biotech
IPOs
IQVIA
4 biotechs to watch in 2024
Pharma Voice
Wed, 02/21/24 - 11:28 am
biotech
IPOs
Alto Neuroscience
Verona Pharma
Karuna Therapeutics
Madrigal Pharmaceuticals
precision medicine
COPD
Alzheimer's disease
NASH
Bayer, Moderna-Backed Metagenomi’s Stock Crashes 31% in Friday IPO Debut
BioSpace
Mon, 02/12/24 - 11:51 am
Metagenomi
Bayer
IPOs
Kyverna CEO Peter Maag on courting investors in a ‘volatile’ IPO market
BioPharma Dive
Mon, 02/12/24 - 11:47 am
Kyverna Therapeutics
IPOs
Peter Maag
Gene editing biotech Metagenomi pulls off nearly $94M IPO
BioPharma Dive
Sun, 02/11/24 - 03:52 pm
IPOs
Metagenomi
gene editing
Kyverna IPO adds to biotech momentum with $319M fundraise
BioPharma Dive
Thu, 02/8/24 - 11:07 am
Kyverna Therapeutics
IPOs
autoimmune diseases
Gilead-backed Kyverna Therapeutics aims for $857.3 mln valuation in upsized IPO
Reuters
Tue, 02/6/24 - 09:17 am
Kyvera Therapeutics
IPOs
Gilead Sciences
autoimmune diseases
Fractyl Breaks the Medical Device IPO Drought with New Offering
Medical Devices and Diagnostics Industry
Sun, 02/4/24 - 12:37 pm
Fractyl Health
IPOs
diabetes
obesity
Medtech
Brain drug developer Alto Neuroscience prices $129M IPO
BioPharma Dive
Fri, 02/2/24 - 11:39 am
Alto Neuroscience
IPOs
CNS
Kyverna sets IPO range, eyeing $180M haul to fund broad autoimmune CAR-T clinical trial program
Fierce Biotech
Thu, 02/1/24 - 11:19 am
Kyverna Therapeutics
IPOs
cell therapy
autoimmune disease
Fractyl sets out $99M IPO ambitions after busy week of biotechs going public
Fierce Biotech
Mon, 01/29/24 - 11:13 am
IPOs
Fractyl Health
obesity
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »